Tenax Therapeutics earnings were -$24.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest TENX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$10.4M, up 66.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TENX reported annual earnings of -$17.6M, with 128.3% growth.
What were Tenax Therapeutics's earnings last quarter?
On TENX's earnings call on Invalid Date, Tenax Therapeutics (NASDAQ: TENX) reported Q1 2025 earnings per share (EPS) of -$0.28, up 91.03% year over year. Total TENX earnings for the quarter were -$10.41 million. In the same quarter last year, Tenax Therapeutics's earnings per share (EPS) was -$3.12.
As of the last Tenax Therapeutics earnings report, Tenax Therapeutics is currently losing money. Tenax Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$24.21 million, a 139.64% increase year over year.
What was TENX's earnings growth in the past year?
As of Tenax Therapeutics's earnings date in Invalid Date, Tenax Therapeutics's earnings has grown year over year. TENX earnings in the past year totalled -$24.21 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.